|
|
Volumn , Issue , 2005, Pages 335-339
|
|
Targeting CD20 in follicular NHL: novel anti-CD20 therapies, antibody engineering, and the use of radioimmunoconjugates.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IBRITUMOMAB TIUXETAN;
IMMUNOLOGIC FACTOR;
IODINE 131 ANTI B1 ANTIBODY;
IODINE-131 ANTI-B1 ANTIBODY;
MONOCLONAL ANTIBODY;
RADIOACTIVE IODINE;
RITUXIMAB;
YTTRIUM;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ARTICLE;
B CELL LYMPHOMA;
CYTOTOXICITY TEST;
DRUG RESISTANCE;
HUMAN;
IMMUNOLOGY;
METHODOLOGY;
NONHODGKIN LYMPHOMA;
RADIOIMMUNOTHERAPY;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
ANTINEOPLASTIC AGENTS;
CYTOTOXICITY TESTS, IMMUNOLOGIC;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
IMMUNOLOGIC FACTORS;
IODINE RADIOISOTOPES;
LYMPHOMA, B-CELL;
LYMPHOMA, NON-HODGKIN;
RADIOIMMUNOTHERAPY;
YTTRIUM RADIOISOTOPES;
|
|
EID: 33745474700
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2005.1.335 Document Type: Article |
|
Times cited : (20)
|
|
References (0)
|
